tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
BioCryst receives early termination of HSR waiting period for Astria acquisition
PremiumThe FlyBioCryst receives early termination of HSR waiting period for Astria acquisition
2M ago
Astria Therapeutics Reports Q3 2025 Results and BioCryst Acquisition
Premium
Company Announcements
Astria Therapeutics Reports Q3 2025 Results and BioCryst Acquisition
2M ago
Astria Therapeutics: Hold Rating Amid Acquisition and Financial Stability with Future Growth Prospects
Premium
Ratings
Astria Therapeutics: Hold Rating Amid Acquisition and Financial Stability with Future Growth Prospects
2M ago
Astria Therapeutics Advances Phase 3 Trial for Hereditary Angioedema Treatment
PremiumCompany AnnouncementsAstria Therapeutics Advances Phase 3 Trial for Hereditary Angioedema Treatment
3M ago
Astria Therapeutics’ STAR-0310 Study: A Promising Step Forward
Premium
Company Announcements
Astria Therapeutics’ STAR-0310 Study: A Promising Step Forward
3M ago
Astria Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Astria Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
3M ago
BioCryst reinstated with a Buy at TD Cowen
PremiumThe FlyBioCryst reinstated with a Buy at TD Cowen
3M ago
Astria Therapeutics downgraded to Perform from Outperform at Oppenheimer
Premium
The Fly
Astria Therapeutics downgraded to Perform from Outperform at Oppenheimer
3M ago
BioCryst weakness presents ‘compelling’ buying opportunity, says RBC
Premium
The Fly
BioCryst weakness presents ‘compelling’ buying opportunity, says RBC
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100